List of Excipients in API amlodipine and valsartan
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing amlodipine and valsartan
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 | CELLULOSE, MICROCRYSTALLINE |
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 | CROSPOVIDONE |
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 | FERRIC OXIDE RED |
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 | FERRIC OXIDE YELLOW |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for amlodipine and valsartan
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine and valsartan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 |
| Macleods Pharmaceuticals Limited | amlodipine and valsartan | 33342-279 |
| Novel Laboratories Inc | amlodipine and valsartan | 40032-083 |
| Lupin PharmaceuticalsInc | amlodipine and valsartan | 43386-083 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSPOVIDONE
amlodipine and valsartan drug variants containing CROSPOVIDONE
amlodipine and valsartan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-880 |
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| LUPIN LIMITED | amlodipine and valsartan | 57297-764 |
| Aurobindo Pharma Limited | amlodipine and valsartan | 65862-737 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
amlodipine and valsartan drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 |
| medsource pharmaceuticals | amlodipine and valsartan | 45865-880 |
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| Alembic Pharmaceuticals Limited | amlodipine and valsartan | 46708-458 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
amlodipine and valsartan drug variants containing FERRIC OXIDE YELLOW
amlodipine and valsartan drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYPROMELLOSE
amlodipine and valsartan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
amlodipine and valsartan drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| Alembic Pharmaceuticals Limited | amlodipine and valsartan | 46708-458 |
| Alembic Pharmaceuticals Inc | amlodipine and valsartan | 62332-205 |
| Aurobindo Pharma Limited | amlodipine and valsartan | 65862-737 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
amlodipine and valsartan drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | amlodipine and valsartan | 33342-279 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
amlodipine and valsartan drug variants containing MAGNESIUM STEARATE
amlodipine and valsartan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-880 |
| LUPIN LIMITED | amlodipine and valsartan | 57297-764 |
| Lupin Pharmaceuticals Inc | amlodipine and valsartan | 68180-764 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
amlodipine and valsartan drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | amlodipine and valsartan | 40032-083 |
| Lupin PharmaceuticalsInc | amlodipine and valsartan | 43386-083 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
amlodipine and valsartan drug variants containing MICROCRYSTALLINE CELLULOSE 102
amlodipine and valsartan drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 |
| Macleods Pharmaceuticals Limited | amlodipine and valsartan | 33342-279 |
| Novel Laboratories Inc | amlodipine and valsartan | 40032-083 |
| Lupin PharmaceuticalsInc | amlodipine and valsartan | 43386-083 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
amlodipine and valsartan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
amlodipine and valsartan drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| Aurobindo Pharma Limited | amlodipine and valsartan | 65862-737 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
amlodipine and valsartan drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | amlodipine and valsartan | 33342-279 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
amlodipine and valsartan drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | amlodipine and valsartan | 46708-458 |
| Alembic Pharmaceuticals Inc | amlodipine and valsartan | 62332-205 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POVIDONE K30
amlodipine and valsartan drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| Aurobindo Pharma Limited | amlodipine and valsartan | 65862-737 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
amlodipine and valsartan drug variants containing SILICON DIOXIDE
amlodipine and valsartan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-880 |
| LUPIN LIMITED | amlodipine and valsartan | 57297-764 |
| Lupin Pharmaceuticals Inc | amlodipine and valsartan | 68180-764 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine and valsartan drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | amlodipine and valsartan | 40032-083 |
| Lupin PharmaceuticalsInc | amlodipine and valsartan | 43386-083 |
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| Aurobindo Pharma Limited | amlodipine and valsartan | 65862-737 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
amlodipine and valsartan drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | amlodipine and valsartan | 0378-1721 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: STARCH, CORN
amlodipine and valsartan drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| medsource pharmaceuticals | amlodipine and valsartan | 45865-890 |
| Aurobindo Pharma Limited | amlodipine and valsartan | 65862-737 |
| >Company | >Ingredient | >NDC |
amlodipine and valsartan drug variants not containing STARCH, CORN
Excipient focus: TALC
amlodipine and valsartan drug variants containing TALC
amlodipine and valsartan drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
amlodipine and valsartan drug variants containing TITANIUM DIOXIDE
amlodipine and valsartan drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
